# Innara

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/innara

- Industry: Medical Devices & Equipment
- Headquarters: Olathe, US
- Website: www.innarahealth.com
- Total disclosed funding: $14M
- Latest round: Series B (Apr 27, 2015)
- Investors on record: 4

## About

Innara, Inc. is a healthcare company focused on enhancing neonatal care through innovative medical devices that support premature infants in their transition to independent feeding.Innara, Inc. specializes in developing technologies for neonatal care, founded in 2006 and headquartered in Olathe, US. The company has completed five deals, with its most recent deal occurring on April 18, 2016, when it raised USD 1.25 mn in VENTURE DEBT financing from KCRise Fund, bringing its total funding to USD 3.70 mn. The CEO, Chris Mathia, has a history of leadership in the healthcare sector, although details about other companies he may have founded are not available.Innara, Inc.'s primary product, the Kangaroo™ NTrainer™ System 2.0, is designed to improve neonatal care by aiding premature infants in the Neonatal Intensive Care Unit (NICU) to move towards independent oral feeding. This system enables real-time assessments and therapies that enhance oral coordination in infants, promoting quicker feeding processes and reducing hospital stays. The Kangaroo™ NTrainer™ System 2.0 is validated to enhance sucking patterns and is targeted at healthcare providers in NICUs across the US and selected international markets, addressing the essential needs of premature infants and facilitating earlier discharges.The revenue for the Kangaroo™ NTrainer™ System 2.0 primarily stems from B2B transactions with healthcare institutions, including hospitals and NICUs. These institutions integrate the system into their neonatal care offerings, often utilizing negotiated pricing for bulk purchases, which aligns with their budgets and healthcare requirements. The product's role in neonatal care protocols is supported by Innara, Inc.'s robust distribution network, ensuring accessibility across various regions.As part of its growth strategy, Innara, Inc. plans to leverage the recent funding of USD 1.25 mn raised in April 2016 to enhance its product offerings and expand into new markets. The company is focused on designing additional products that will improve neonatal care and is exploring opportunities to enter international markets by 2025. The funding will support the development and marketing of its new offerings and assist in market analysis for targeted expansions.

## Funding rounds

- Series B, Apr 27, 2015, $3.7M — Open Prairie, Kansas Bioscience Authority, Flyover Capital
- Series A, Jan 30, 2013, $7M — Serra Ventures
- Series A, Dec 31, 2010, $3M — Open Prairie, Kansas Bioscience Authority

## Investors

- Open Prairie (https://capitalatlas.ai/funds/open-prairie) — Series A, Series B
- Kansas Bioscience Authority — Series A, Series B
- Serra Ventures (https://capitalatlas.ai/funds/serra-ventures) — Series A
- Flyover Capital (https://capitalatlas.ai/funds/flyover-capital) — Series B